(Press-News.org) Montreal − A team of researchers from Montreal has found that stroke patients living with Locked-In Syndrome (LIS) who cannot move, swallow or even breathe on their own, can regain a remarkable level of independence with technological help.
The team's findings, to be presented at the Canadian Stroke Congress, stem from a 20-year study that followed the rehabilitation of 25 LIS patients, people who are aware and awake but cannot move or communicate verbally due to complete paralysis of nearly all voluntary muscles.
"These patients can achieve a remarkable level of independence in communication and mobility with the use of rehabilitation and technological help," says researcher Dr. Nicole Beaudoin, specialist in physical medicine and rehabilitation in the neurology program and chief of rehabilitation at the Institut de réadaptation Gingras-Lindsay de Montréal. "They have a strong will to live and we help improve the quality of their lives."
LIS results from a lesion to the brainstem, which can occur when a stroke impacts this specific small area at the junction between the spinal cord and the left and right hemispheres of the brain. The lesion blocks the brain's motor pathways, resulting in almost complete paralysis.
The majority of patients in this study received training to use some form of technology that could enhance their independence.
Forty per cent succeeded in using a cephalic control ─ a joystick activated by the movements of the head ─ to drive a wheelchair.
Twenty five per cent were able to use a head mouse emulator ─ a little reflector placed on the forehead that sends information to a small receptor in a computer ─ allowing them to use the computer.
Others, who had even more limited movement, require more sophisticated computerized interfaces to activate a scanning system, which permits combined computer-supported communication and safe wheelchair control.
"In spite of considerable motor disabilities, many patients achieved a high level of autonomy to communicate and to control a motorized wheelchair," says Dr. Beaudoin. "Advances in technology can dramatically improve independence for LIS patients."
Though these patients are virtually completely immobile, they are sometimes left with the ability to make a one- or two-degree movement of the head, a twitch of a finger or toe, or an eye movement. These minimal functions can open up their world in many ways.
Some patients in this study, for example, learned to operate a motorized wheelchair or control a mouse to access a computer with just the slightest head movement. Others could use eye tracking to access an interface with words or symbols, allowing them to be heard.
One patient has a switch under her first toe, and with that she can write, communicate, send emails, and play computer games, and her words are translated into sound.
Another patient had originally spent a year on his back, staring at the ceiling. At the time, no one knew he could communicate with his eyes. With the right technology, now he can let his caregivers know of his needs.
"We see that advances in technology can greatly improve independence and the lives of many people following a stroke, including those with LIS," says Ian Joiner, director of stroke at the Heart and Stroke Foundation. "These results underscore how rehabilitation can have a huge positive impact, even when the outcomes appear very grave at first."
"Locked-in syndrome, beautifully shown in the French film The Diving Bell and the Butterfly, occurs with major brainstem stroke," says Dr. Michael Hill, Canadian Stroke Congress co-chair. "It leaves patients fully conscious, aware and mentally competent but completely paralyzed. These remarkable developments in assistive technology can allow victims of this uncommon stroke type, the full re-expression of their humanity."
Until now, there has been little Canadian data on the functional outcome of people living with LIS.
###
The Canadian Stroke Congress is a joint initiative of the Canadian Stroke Network, Heart and Stroke Foundation of Canada and Canadian Stroke Consortium.
Statements and conclusions of study authors are solely those of the study authors and do not necessarily reflect Vascular 2013 host organizations' policy or position. They make no representation or warranty as to their accuracy or reliability.
The Canadian Stroke Network, canadianstrokenetwork.ca, is a national research network headquartered at the University of Ottawa. It includes scientists, clinicians and health-policy experts committed to reducing the impact of stroke.
The Heart and Stroke Foundation's mission is to prevent disease, save lives and promote recovery. A volunteer-based health charity, we strive to tangibly improve the health of every Canadian family, every day. 'Healthy lives free of heart disease and stroke. Together we will make it happen.' Heartandstroke.ca
Vascular 2013 is a unique, one-time Canadian event bringing four separate scientific meetings together under one roof: the Canadian Cardiovascular Congress, the Canadian Diabetes Association/Canadian Society of Endocrinology and Metabolism Professional Conference, the Canadian Stroke Congress and the Canadian Hypertension Congress. vascular2013.ca
It is a joint initiative of the Canadian Cardiovascular Society, Canadian Diabetes Association/Canadian Society of Endocrinology and Metabolism, the Canadian Stroke Network, the Heart and Stroke Foundation, and Hypertension Canada.
For more information and/or interviews, contact the
VASCULAR 2013 MEDIA OFFICE AT 514-789-3402 (Oct 17-20)
OR
Massy Forget Langlois Public Relations
Christian Ahuet, Consultant
514-842-2455, ext. 29 / Cell 514-994-7496
Congress information and media registration is at http://www.vascular2013.ca
After October 20, 2013 contact:
Jane-Diane Fraser
Heart and Stroke Foundation
jfraser@hsf.ca
613-569-4361x273
Unlocking a brighter future for locked-in syndrome
Researchers use technology to help immobilized stroke survivors regain some independence
2013-10-17
ELSE PRESS RELEASES FROM THIS DATE:
Eye contact builds bedside trust
2013-10-16
CHICAGO --- Doctors who make a lot of eye contact are viewed as more likable and empathetic by patients, according to a new Northwestern Medicine® study.
Patients also gave doctors higher empathy scores when their total visit length was longer and when doctors engaged in a few "social touches" such as a handshake or pat on the back. However, more than three social touches in one visit decreased empathy scores. The researchers said it's possible that too many social touches from a doctor may seem forced and not genuine to a patient.
The study, published in the Journal ...
UCSB researcher reveals the brain connections underlying accurate introspection
2013-10-16
(Santa Barbara, Calif.) –– The human mind is not only capable of cognition and registering experiences but also of being introspectively aware of these processes. Until now, scientists have not known if such introspection was a single skill or dependent on the object of reflection. Also unclear was whether the brain housed a single system for reflecting on experience or required multiple systems to support different types of introspection.
A new study by UC Santa Barbara graduate student Benjamin Baird and colleagues suggest that the ability to accurately reflect on perceptual ...
New blood test could help millions of patients with gastrointestinal disorders
2013-10-16
LOS ANGELES (Oct. 15, 2013) – For the first time, a simple blood test may be the best way to determine if a patient is suffering from Irritable Bowel Syndrome (IBS), or another serious condition such as Inflammatory Bowel Disease (IBD,) according to Cedars-Sinai physician researcher Mark Pimentel, MD, lead author of a multicenter clinical trial.
Researchers conclusively identified a test for antibodies that form against a particular protein, vinculin, found in the guts of patients, many of whom suffered acute gastroenteritis at some point.
"This is a major breakthrough. ...
Researchers discover and treat toxic effects of ALS mutation in neurons made from patients' skin cells
2013-10-16
Researchers have discovered how the most common genetic abnormality in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) kills neurons and have successfully developed a therapeutic strategy to block this neurodegeneration in neurons made from the skin cells of ALS patients. The findings, which are published online in the October 16th issue of the Cell Press journal Neuron, have important implications for treating patients with these debilitating, currently incurable neurodegenerative diseases.
The most common genetic mutation in ALS and FTD is an abnormal ...
Rare gene mutation sheds light on protein's role in brain development
2013-10-16
DURHAM, N.C. – Though worlds apart, four unrelated families have been united in a medical mystery over the source of a rare inherited disorder that results in their children being born with abnormal brain growth and severe functional impairments.
An international team of scientists, led by genetic researchers at Duke Medicine, has solved the case by identifying a recessive gene mutation that reduces the abundance of a certain protein that previously had not been known to affect brain development.
The gene mutation causes a defect in the body's synthesis of a nutrient ...
'Individualized' therapy for the brain targets specific gene mutations causing dementia and ALS
2013-10-16
Johns Hopkins scientists have developed new drugs that — at least in a laboratory dish — appear to halt the brain-destroying impact of a genetic mutation at work in some forms of two incurable diseases, amyotrophic lateral sclerosis (ALS) and dementia.
They made the finding by using neurons they created from stem cells known as induced pluripotent stem cells (iPS cells), which are derived from the skin of people with ALS who have a gene mutation that interferes with the process of making proteins needed for normal neuron function.
"Efforts to treat neurodegenerative ...
Study shows how Staph toxin disarms the immune system
2013-10-16
Researchers at NYU Langone Medical Center have discovered a new mechanism by which the deadly Staphylococcus aureus bacteria attack and kill off immune cells. Their findings, published today in the journal Cell Host & Microbe, explain a critical survival tactic of a pathogen that causes more skin and heart infections than any other microbe, and kills more than 100,000 Americans every year.
"What we've found is that Staph unleashes a multi-purpose toxin capable of killing different types of immune cells by selectively binding to surface receptors," says Victor J. Torres, ...
ALMA probes mysteries of jets from giant black holes
2013-10-16
There are supermassive black holes -- with masses up to several billion solar masses -- at the hearts of almost all galaxies in the Universe, including our own galaxy, the Milky Way. In the remote past, these bizarre objects were very active, swallowing enormous quantities of matter from their surroundings, shining with dazzling brilliance, and expelling tiny fractions of this matter through extremely powerful jets. In the current Universe, most supermassive black holes are much less active than they were in their youth, but the interplay between jets and their surroundings ...
Over 1 million community health center patients will remain uninsured and left out of health reform
2013-10-16
WASHINGTON, DC and NEW YORK (Oct. 16, 2013)— A new report by the Geiger Gibson/RCHN Community Health Foundation Research Collaborative at the George Washington University School of Public Health and Health Services (SPHHS) examines the impact of health reform on community health centers (CHCs) and their patients. "Assessing the Potential Impact of the Affordable Care Act on Uninsured Community Health Center Patients: A Nationwide and State-by-State Analysis," estimates that more than 5 million health center patients would have gained coverage had all states participated ...
Mice modeling schizophrenia show key brain network in overdrive
2013-10-16
Working with mice genetically engineered to display symptoms of schizophrenia, neuroscientists at the RIKEN-MIT Center for Neural Circuit Genetics at the Picower Institute for Learning and Memory at MIT have uncovered a faulty brain mechanism that may underlie schizophrenia and other psychiatric disorders in humans.
The study, to appear in the Oct. 16 issue of Neuron, is the first to tie a specific brain network abnormality to schizophrenia, whose symptoms range from disorganized thinking, hallucinations and paranoia to an inability to plan for the future.
"Our study ...
LAST 30 PRESS RELEASES:
Science briefing: An update on GLP-1 drugs for obesity
Lower doses of immunotherapy for skin cancer give better results
Why didn’t the senior citizen cross the road? Slower crossings may help people with reduced mobility
ASH 2025: Study suggests that a virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment
A sound defense: Noisy pupae puff away potential predators
Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy
Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes
New findings support a chemo-free approach for treating Ph+ ALL
Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL
University of Cincinnati experts present research at annual hematology event
ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial
ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer
ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors
Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient
Continuous and fixed-duration treatments result in similar outcomes for CLL
Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia
Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease
Roughly one-third of families with children being treated for leukemia struggle to pay living expenses
Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy
IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection
Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients
Emergency departments fall short on delivering timely treatment for sickle cell pain
Study shows no clear evidence of harm from hydroxyurea use during pregnancy
Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease
Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia
Early results suggest exa-cel gene therapy works well in children
NTIDE: Disability employment holds steady after data hiatus
Social lives of viruses affect antiviral resistance
Dose of psilocybin, dash of rabies point to treatment for depression
Helping health care providers navigate social, political, and legal barriers to patient care
[Press-News.org] Unlocking a brighter future for locked-in syndromeResearchers use technology to help immobilized stroke survivors regain some independence